Global Complement Targeted Therapeutics Market Research Report 2023

Report ID: 1875659 | Published Date: Oct 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Complement Targeted Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Paroxysmal Nocturnal Haemoglobinuria
        1.2.3 Atypical Haemolytic Uraemic Syndrome (AHUS)
    1.3 Market by Application
        1.3.1 Global Complement Targeted Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharamacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Complement Targeted Therapeutics Market Perspective (2018-2029)
    2.2 Complement Targeted Therapeutics Growth Trends by Region
        2.2.1 Global Complement Targeted Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Complement Targeted Therapeutics Historic Market Size by Region (2018-2023)
        2.2.3 Complement Targeted Therapeutics Forecasted Market Size by Region (2024-2029)
    2.3 Complement Targeted Therapeutics Market Dynamics
        2.3.1 Complement Targeted Therapeutics Industry Trends
        2.3.2 Complement Targeted Therapeutics Market Drivers
        2.3.3 Complement Targeted Therapeutics Market Challenges
        2.3.4 Complement Targeted Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Complement Targeted Therapeutics Players by Revenue
        3.1.1 Global Top Complement Targeted Therapeutics Players by Revenue (2018-2023)
        3.1.2 Global Complement Targeted Therapeutics Revenue Market Share by Players (2018-2023)
    3.2 Global Complement Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Complement Targeted Therapeutics Revenue
    3.4 Global Complement Targeted Therapeutics Market Concentration Ratio
        3.4.1 Global Complement Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Complement Targeted Therapeutics Revenue in 2022
    3.5 Complement Targeted Therapeutics Key Players Head office and Area Served
    3.6 Key Players Complement Targeted Therapeutics Product Solution and Service
    3.7 Date of Enter into Complement Targeted Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Targeted Therapeutics Breakdown Data by Type
    4.1 Global Complement Targeted Therapeutics Historic Market Size by Type (2018-2023)
    4.2 Global Complement Targeted Therapeutics Forecasted Market Size by Type (2024-2029)
5 Complement Targeted Therapeutics Breakdown Data by Application
    5.1 Global Complement Targeted Therapeutics Historic Market Size by Application (2018-2023)
    5.2 Global Complement Targeted Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Complement Targeted Therapeutics Market Size (2018-2029)
    6.2 North America Complement Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Complement Targeted Therapeutics Market Size by Country (2018-2023)
    6.4 North America Complement Targeted Therapeutics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Complement Targeted Therapeutics Market Size (2018-2029)
    7.2 Europe Complement Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Complement Targeted Therapeutics Market Size by Country (2018-2023)
    7.4 Europe Complement Targeted Therapeutics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Complement Targeted Therapeutics Market Size (2018-2029)
    8.2 Asia-Pacific Complement Targeted Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Complement Targeted Therapeutics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Complement Targeted Therapeutics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Complement Targeted Therapeutics Market Size (2018-2029)
    9.2 Latin America Complement Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Complement Targeted Therapeutics Market Size by Country (2018-2023)
    9.4 Latin America Complement Targeted Therapeutics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Complement Targeted Therapeutics Market Size (2018-2029)
    10.2 Middle East & Africa Complement Targeted Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Complement Targeted Therapeutics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Complement Targeted Therapeutics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Creative Biolabs
        11.1.1 Creative Biolabs Company Detail
        11.1.2 Creative Biolabs Business Overview
        11.1.3 Creative Biolabs Complement Targeted Therapeutics Introduction
        11.1.4 Creative Biolabs Revenue in Complement Targeted Therapeutics Business (2018-2023)
        11.1.5 Creative Biolabs Recent Development
    11.2 Novartis AG
        11.2.1 Novartis AG Company Detail
        11.2.2 Novartis AG Business Overview
        11.2.3 Novartis AG Complement Targeted Therapeutics Introduction
        11.2.4 Novartis AG Revenue in Complement Targeted Therapeutics Business (2018-2023)
        11.2.5 Novartis AG Recent Development
    11.3 Alexion Pharmaceuticals
        11.3.1 Alexion Pharmaceuticals Company Detail
        11.3.2 Alexion Pharmaceuticals Business Overview
        11.3.3 Alexion Pharmaceuticals Complement Targeted Therapeutics Introduction
        11.3.4 Alexion Pharmaceuticals Revenue in Complement Targeted Therapeutics Business (2018-2023)
        11.3.5 Alexion Pharmaceuticals Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Complement Targeted Therapeutics Introduction
        11.4.4 Merck Revenue in Complement Targeted Therapeutics Business (2018-2023)
        11.4.5 Merck Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Detail
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Complement Targeted Therapeutics Introduction
        11.5.4 Pfizer Revenue in Complement Targeted Therapeutics Business (2018-2023)
        11.5.5 Pfizer Recent Development
    11.6 Allergan
        11.6.1 Allergan Company Detail
        11.6.2 Allergan Business Overview
        11.6.3 Allergan Complement Targeted Therapeutics Introduction
        11.6.4 Allergan Revenue in Complement Targeted Therapeutics Business (2018-2023)
        11.6.5 Allergan Recent Development
    11.7 AbbVie
        11.7.1 AbbVie Company Detail
        11.7.2 AbbVie Business Overview
        11.7.3 AbbVie Complement Targeted Therapeutics Introduction
        11.7.4 AbbVie Revenue in Complement Targeted Therapeutics Business (2018-2023)
        11.7.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Complement Targeted Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Paroxysmal Nocturnal Haemoglobinuria
    Table 3. Key Players of Atypical Haemolytic Uraemic Syndrome (AHUS)
    Table 4. Global Complement Targeted Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Complement Targeted Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Complement Targeted Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Complement Targeted Therapeutics Market Share by Region (2018-2023)
    Table 8. Global Complement Targeted Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Complement Targeted Therapeutics Market Share by Region (2024-2029)
    Table 10. Complement Targeted Therapeutics Market Trends
    Table 11. Complement Targeted Therapeutics Market Drivers
    Table 12. Complement Targeted Therapeutics Market Challenges
    Table 13. Complement Targeted Therapeutics Market Restraints
    Table 14. Global Complement Targeted Therapeutics Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Complement Targeted Therapeutics Market Share by Players (2018-2023)
    Table 16. Global Top Complement Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Targeted Therapeutics as of 2022)
    Table 17. Ranking of Global Top Complement Targeted Therapeutics Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Complement Targeted Therapeutics Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Complement Targeted Therapeutics Product Solution and Service
    Table 21. Date of Enter into Complement Targeted Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Complement Targeted Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Complement Targeted Therapeutics Revenue Market Share by Type (2018-2023)
    Table 25. Global Complement Targeted Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Complement Targeted Therapeutics Revenue Market Share by Type (2024-2029)
    Table 27. Global Complement Targeted Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Complement Targeted Therapeutics Revenue Market Share by Application (2018-2023)
    Table 29. Global Complement Targeted Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Complement Targeted Therapeutics Revenue Market Share by Application (2024-2029)
    Table 31. North America Complement Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Complement Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Complement Targeted Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Complement Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Complement Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Complement Targeted Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Complement Targeted Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Complement Targeted Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Complement Targeted Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Complement Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Complement Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Complement Targeted Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Complement Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Complement Targeted Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Complement Targeted Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Creative Biolabs Company Detail
    Table 47. Creative Biolabs Business Overview
    Table 48. Creative Biolabs Complement Targeted Therapeutics Product
    Table 49. Creative Biolabs Revenue in Complement Targeted Therapeutics Business (2018-2023) & (US$ Million)
    Table 50. Creative Biolabs Recent Development
    Table 51. Novartis AG Company Detail
    Table 52. Novartis AG Business Overview
    Table 53. Novartis AG Complement Targeted Therapeutics Product
    Table 54. Novartis AG Revenue in Complement Targeted Therapeutics Business (2018-2023) & (US$ Million)
    Table 55. Novartis AG Recent Development
    Table 56. Alexion Pharmaceuticals Company Detail
    Table 57. Alexion Pharmaceuticals Business Overview
    Table 58. Alexion Pharmaceuticals Complement Targeted Therapeutics Product
    Table 59. Alexion Pharmaceuticals Revenue in Complement Targeted Therapeutics Business (2018-2023) & (US$ Million)
    Table 60. Alexion Pharmaceuticals Recent Development
    Table 61. Merck Company Detail
    Table 62. Merck Business Overview
    Table 63. Merck Complement Targeted Therapeutics Product
    Table 64. Merck Revenue in Complement Targeted Therapeutics Business (2018-2023) & (US$ Million)
    Table 65. Merck Recent Development
    Table 66. Pfizer Company Detail
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Complement Targeted Therapeutics Product
    Table 69. Pfizer Revenue in Complement Targeted Therapeutics Business (2018-2023) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. Allergan Company Detail
    Table 72. Allergan Business Overview
    Table 73. Allergan Complement Targeted Therapeutics Product
    Table 74. Allergan Revenue in Complement Targeted Therapeutics Business (2018-2023) & (US$ Million)
    Table 75. Allergan Recent Development
    Table 76. AbbVie Company Detail
    Table 77. AbbVie Business Overview
    Table 78. AbbVie Complement Targeted Therapeutics Product
    Table 79. AbbVie Revenue in Complement Targeted Therapeutics Business (2018-2023) & (US$ Million)
    Table 80. AbbVie Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Complement Targeted Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Complement Targeted Therapeutics Market Share by Type: 2022 VS 2029
    Figure 3. Paroxysmal Nocturnal Haemoglobinuria Features
    Figure 4. Atypical Haemolytic Uraemic Syndrome (AHUS) Features
    Figure 5. Global Complement Targeted Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Complement Targeted Therapeutics Market Share by Application: 2022 VS 2029
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharamacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Complement Targeted Therapeutics Report Years Considered
    Figure 11. Global Complement Targeted Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Complement Targeted Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Complement Targeted Therapeutics Market Share by Region: 2022 VS 2029
    Figure 14. Global Complement Targeted Therapeutics Market Share by Players in 2022
    Figure 15. Global Top Complement Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Targeted Therapeutics as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Complement Targeted Therapeutics Revenue in 2022
    Figure 17. North America Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Complement Targeted Therapeutics Market Share by Country (2018-2029)
    Figure 19. United States Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Complement Targeted Therapeutics Market Share by Country (2018-2029)
    Figure 23. Germany Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Complement Targeted Therapeutics Market Share by Region (2018-2029)
    Figure 31. China Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Complement Targeted Therapeutics Market Share by Country (2018-2029)
    Figure 39. Mexico Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Complement Targeted Therapeutics Market Share by Country (2018-2029)
    Figure 43. Turkey Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Complement Targeted Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Creative Biolabs Revenue Growth Rate in Complement Targeted Therapeutics Business (2018-2023)
    Figure 46. Novartis AG Revenue Growth Rate in Complement Targeted Therapeutics Business (2018-2023)
    Figure 47. Alexion Pharmaceuticals Revenue Growth Rate in Complement Targeted Therapeutics Business (2018-2023)
    Figure 48. Merck Revenue Growth Rate in Complement Targeted Therapeutics Business (2018-2023)
    Figure 49. Pfizer Revenue Growth Rate in Complement Targeted Therapeutics Business (2018-2023)
    Figure 50. Allergan Revenue Growth Rate in Complement Targeted Therapeutics Business (2018-2023)
    Figure 51. AbbVie Revenue Growth Rate in Complement Targeted Therapeutics Business (2018-2023)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Creative Biolabs
Novartis AG
Alexion Pharmaceuticals
Merck
Pfizer
Allergan
AbbVie
Frequently Asked Questions
Complement Targeted Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Complement Targeted Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Complement Targeted Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Apolipoprotein Test

This report aims to provide a comprehensive presentation of the global market for Apolipoprotein  ... Read More